Media Room

Search Content Sitemap

James CCC > Media Room

Media Room

Featured Story

Delayed Treatment for Breast Cancer Has 'Profound Effect'

For broadcast quality video and photos, visit our media center.

Oncolytic Virus Extends Survival In Medulloblastoma Model Medulloblastoma is the most common malignant brain tumor in children. Disseminated medulloblastoma is particularly lethal and requires extensive radiation therapy to the brain, which can cause bra 2/14/2012
Understanding How Early Breast Tumors Become Deadly: A Small Group Of Molecules Might Hold The Answer Some early-stage breast cancers are potentially harmless, but others invade surrounding healthy tissue and become deadly. This study has identified a small pattern of molecules that highlights impo 2/7/2012
Leaders From South Korea’s Cancer Center Travel To Ohio State To Learn Best Practices In Cancer Research And Care COLUMBUS, Ohio – Leaders from Samsung Cancer Center, located in Seoul, South Korea, traveled 7,000 miles, flying for more than a day and crossing 14 hours in time zones, just to have the opportunity t 2/3/2012
Oral HPV Infection is Three Times More Common in Men than Women, Study Shows First author and study leader Dr. Maura Gillison, medical oncologist and head and neck cancer specialist at the OSUCCC – James, describes the findings of her paper, “Prevalence of Oral HPV Infect 1/26/2012
Study Reveals Mechanism Of Lung-Cancer Drug Resistance The most common form of lung cancer inevitably develops resistance to the targeted drug gefitinib. This study shows how this resistance develops. The findings suggest a new strategy for treating non 1/19/2012
Dr. Caligiuri to Host 'Fireside Chat' About the Future of Cancer Research COLUMBUS, Ohio – Michael A. Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute, will discuss the future 1/13/2012
Anti-Sense Might Make Sense For Treating Liver Cancer COLUMBUS, Ohio – A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this malignanc 1/3/2012
Ohio State Scientist Receives AMP Award For Excellence COLUMBUS, Ohio – Dr. Carlo M. Croce, chair of the department of molecular virology, immunology, and medical genetics; and director of Human Cancer Genetics at Ohio State, received the Association for 12/29/2011
Pelotonia To Fund 5 Postdoctoral Fellows At Ohio State COLUMBUS, Ohio – The Pelotonia Fellowship Program, which is funded by the annual Pelotonia cycling event, will award grants to five postdoctoral students to conduct innovative cancer research at The 12/29/2011
Pelotonia To Fund Additional Cancer Research At Ohio State COLUMBUS, Ohio – Six teams of scientists at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are each 12/22/2011
Study Reveals How Normal Cells Fuel Tumor Growth Research summary: · The study shows how normal cells in tumors can enhance the growth of the tumor’s cancer cells after losing an important tumor suppressor gene called Pten. · 12/21/2011
Hope Supports The New James Cancer Hospital And Solove Research Institute COLUMBUS, Ohio – A 31-foot steel beam carrying messages of hope for a cancer-free world from nearly 1,000 James cancer survivors will be installed at 10:30 a.m. Thursday (12/22) at the new Arthur G 12/21/2011
Scientists Discover Second-Oldest Gene Mutation COLUMBUS, Ohio – A new study has identified a gene mutation that researchers estimate dates back to 11,600 B.C., making it the second oldest human disease mutation yet discovered. Researchers wi 12/15/2011
Gene Mutation Signals A High Risk Of Recurrence In Some Older Acute-Leukemia Patients COLUMBUS, Ohio – Older people with acute myeloid leukemia and normal looking chromosomes in their cancer cells have a higher risk of recurrence if they have mutations in a gene called ASXL1, accordi 12/12/2011
Novel Export-Inhibitor Shows Promise For Treating CLL COLUMBUS, Ohio – An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) 12/12/2011
Interim Study Shows Novel Experimental Agent is Highly Active in CLL Patients COLUMBUS, Ohio – An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients w 12/9/2011
Ohio State Researchers Discover Hereditary Predisposition to Melanoma of the Eye COLUMBUS, Ohio – Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and po 12/8/2011
Third Time In Three Years, The James Earns Top Hospital Status COLUMBUS, Ohio – For the third consecutive year and fourth time in five years, the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research I 12/6/2011
A New Study Suggests That A Neurotransmitter Might Improve The Treatment Of Cancer COLUMBUS, Ohio – Doses of a neurotransmitter might offer a way to boost the effectiveness of anticancer drugs and radiation therapy, according to a new study led by researchers at the Ohio State Univ Watch 12/5/2011
Ohio State Studying How Chemotherapy Affects Breast Cancer Patients’ Hearts COLUMBUS, Ohio – Ohio State University cancer and heart researchers are teaming up to find a better way to assess early cardiac injury from a class of chemotherapy drugs commonly used to treat breas Watch 12/5/2011
Lower Antioxidant Level Might Explain Higher Skin-Cancer Rate In Males COLUMBUS, Ohio – Men are three times more likely than women to develop a common form of skin cancer but medical science doesn’t know why. A new study may provide part of the answer. Researchers Watch 12/1/2011
Shapiro to Lead Breast Cancer Research Program at Ohio State COLUMBUS, Ohio – Dr. Charles Shapiro has been named to lead the breast cancer research program at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard 11/30/2011
Ohio State Cancer Expert Joins HemOnc Today Editorial Board COLUMBUS, Ohio – Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove 11/18/2011
NCI Funds Ohio State Breast Cancer Intervention Training COLUMBUS, Ohio – Barbara Andersen, a professor of psychology and researcher at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research I 11/18/2011
NCI Awards OSU Comprehensive Cancer Center $23 Million COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center (OSUCCC) has received a 5-year, $23 million core grant renewal from the National Cancer Institute (NCI) to support its broad 11/11/2011
Pelotonia 11 Raises A Record $13.1 Million COLUMBUS, Ohio -- Pelotonia has announced record fundraising of $13,108,639 for its 2011 ride. This year’s total reflects a 68% fundraising increase over the 2010 amount of $7,846,705. From August 11/11/2011
Stefanie's Champions Seeks Nominations for Caregivers COLUMBUS, Ohio – The 13th annual Stefanie’s Champions Awards is seeking nominations for caregivers who are helping improve the lives of cancer patients. Five Champions will be honored during an annua 11/9/2011
Ohio State Cancer Expert Receives NCI Award For Team Leadership COLUMBUS, Ohio – Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solo 11/2/2011
Cancer Survivorship Research Reveals Disparities COLUMBUS, Ohio – Despite a general increase in research addressing cancer survivorship, researchers have found that a disproportionate number of studies focus on specific tumor sites, prevention, 10/31/2011
Ohio State Cancer Researcher Wins 11th Consecutive Research Grant COLUMBUS, Ohio – Ohio State University cancer researcher, Electra Paskett, has been awarded a grant from the Breast Cancer Research Foundation (BCRF) at the organization’s awards luncheon this week in 10/27/2011
New Oncolytic Virus Shows Improved Effectiveness In Preclinical Testing COLUMBUS, Ohio – A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal 10/27/2011
Internationally Renowned Oncologist Named Physician-In-Chief At Ohio State COLUMBUS, Ohio – Internationally renowned gastrointestinal oncologist Dr. Richard M. Goldberg has been named physician-in-chief at The Ohio State University Comprehensive Cancer Center – Arthur G. Ja Watch 10/27/2011
Ohio State Studies Whether Stress Affects HPV Vaccine Response COLUMBUS, Ohio – Ohio State University cancer researchers are studying whether stress impacts how the body’s immune system responds to the human papillomavirus (HPV) vaccine. The team of investigat 10/25/2011
Ohio State Dedicates Comprehensive Breast Center in Honor of Stefanie Spielman COLUMBUS, Ohio — The Ohio State University President E. Gordon Gee today announced the naming of The Stefanie Spielman Comprehensive Breast Center, in honor of the Ohio State alumna, philanthropist a 10/24/2011
Media Advisory: Ohio Mammography Day to Raise Awareness for Early Detection COLUMBUS, Ohio – Leaders of the Ohio Legislative Cancer Caucus, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUC 10/19/2011
Schottenstein Center To ‘Go Pink’ Today In Honor Of Breast Cancer Awareness Month COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James), The Kroger Company Columbus Division 10/19/2011
Nagy Elected President of National Genetic Counselors COLUMBUS, Ohio – Rebecca Nagy, a certified genetic counselor and researcher at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Res 10/13/2011
Ohio State Cancer Genetics Experts Available For Commentary MEDIA ADVISORY Leading cancer genetics experts from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute availab 10/11/2011
Breast Prosthesis Card Makes Travel Easier COLUMBUS, Ohio – Breast cancer survivors who have prostheses can now travel through airport security with more discretion by using a new identification card developed at the Ohio State University Com 10/7/2011
The James, Kroger and City Hall Team Up To Turn Central Ohio Pink COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James), The Kroger Company Columbus Division 9/29/2011
Media Advisory The James Offering Free Prostate Cancer Screenings COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) is offering free prostate cancer scre 9/27/2011
Novel Technique Reveals Both Gene Number And Protein Expression Simultaneously COLUMBUS, Ohio – Researchers have discovered a method for simultaneously visualizing gene number and protein expression in individual cells. The fluorescence microscopy technique could permit a detail 9/22/2011
Starving Cancer Cells Of Cholesterol Might Offer A New Way To Treat Brain Tumors COLUMBUS, Ohio – A new study suggests that blocking cancer cells’ access to cholesterol may offer a new strategy for treating glioblastoma, the most common and deadly form of brain cancer, and perhap 9/16/2011
James, Kenneth's Salons Team to Offer Screening, Gift COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and Kenneth’s Hair Salons & Day S 9/15/2011
Internationally Renowned Cancer Prevention Expert Takes Leadership Position At Ohio State COLUMBUS, Ohio – Dr. Peter G. Shields, an internationally renowned physician-scientist and expert in cancer prevention, is the new deputy director of The Ohio State University Comprehensive Cancer Ce Watch 9/7/2011
Medicated Patch Shows Promise in Oral Cancer Prevention COLUMBUS, Ohio – Researchers at The Ohio State University Comprehensive Cancer Center have developed a medicated oral patch that allows a chemoprevention drug to release directly into precancerous le Watch 9/1/2011
Annual Block Golf Tournament To Help Fund Expansion Project COLUMBUS, Ohio – The 28th Herbert J. Block Memorial Tournament benefiting The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institu 8/30/2011
Immunogene Therapy Combined With Standard Treatment Is Safe For Patients With Brain Tumors COLUMBUS, Ohio – A clinical trial has shown that a form of gene therapy is safe for treating a deadly form of brain cancer, even when combined with radiation therapy. The phase 1b trial was con Watch 8/15/2011
Pelotonia Fellowships Funding Ohio State Cancer Research COLUMBUS, Ohio – Each year, Pelotonia – a cycling event that raises money for cancer research at The Ohio State University – funds fellowship grants for undergraduate, graduate, medical school and pos 8/11/2011
Ohio State Names Cohn Director of Gynecologic Oncology COLUMBUS, Ohio – Dr. David E. Cohn (43209), a physician-scientist at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (O 8/9/2011

Need Help?

Business hours phone:
614-293-3737

Fax:
614-293-3730

After hours:
614-293-8000
Ask for Hospital Administrative Manager

In the News

Q&A: Genetic Influences on Breast Cancer Risk
Los Angeles times
5/14

Q&A: Genetic Influences on Breast Cancer Risk
USA Today
5/14

Q&A: Genetic Influences on Breast Cancer
FOX News
5/14

Inherited Risk of Lung Cancer? Researchers Launch INHERIT EGFR Registry To Investigate
GenomeWeb
5/14

Pollock Named Director of Surgical Oncology at Ohio State Comprehensive Cancer Center
The Cancer Letter
5/3

Featured Story

Delayed Treatment for Breast Cancer Has 'Profound Effect'

For broadcast quality video and photos, visit our media center.

Oncolytic Virus Extends Survival In Medulloblastoma Model Medulloblastoma is the most common malignant brain tumor in children. Disseminated medulloblastoma is particularly lethal and requires extensive radiation therapy to the brain, which can cause bra 2/14/2012
Understanding How Early Breast Tumors Become Deadly: A Small Group Of Molecules Might Hold The Answer Some early-stage breast cancers are potentially harmless, but others invade surrounding healthy tissue and become deadly. This study has identified a small pattern of molecules that highlights impo 2/7/2012
Leaders From South Korea’s Cancer Center Travel To Ohio State To Learn Best Practices In Cancer Research And Care COLUMBUS, Ohio – Leaders from Samsung Cancer Center, located in Seoul, South Korea, traveled 7,000 miles, flying for more than a day and crossing 14 hours in time zones, just to have the opportunity t 2/3/2012
Oral HPV Infection is Three Times More Common in Men than Women, Study Shows First author and study leader Dr. Maura Gillison, medical oncologist and head and neck cancer specialist at the OSUCCC – James, describes the findings of her paper, “Prevalence of Oral HPV Infect 1/26/2012
Study Reveals Mechanism Of Lung-Cancer Drug Resistance The most common form of lung cancer inevitably develops resistance to the targeted drug gefitinib. This study shows how this resistance develops. The findings suggest a new strategy for treating non 1/19/2012
Dr. Caligiuri to Host 'Fireside Chat' About the Future of Cancer Research COLUMBUS, Ohio – Michael A. Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute, will discuss the future 1/13/2012
Anti-Sense Might Make Sense For Treating Liver Cancer COLUMBUS, Ohio – A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this malignanc 1/3/2012
Ohio State Scientist Receives AMP Award For Excellence COLUMBUS, Ohio – Dr. Carlo M. Croce, chair of the department of molecular virology, immunology, and medical genetics; and director of Human Cancer Genetics at Ohio State, received the Association for 12/29/2011
Pelotonia To Fund 5 Postdoctoral Fellows At Ohio State COLUMBUS, Ohio – The Pelotonia Fellowship Program, which is funded by the annual Pelotonia cycling event, will award grants to five postdoctoral students to conduct innovative cancer research at The 12/29/2011
Pelotonia To Fund Additional Cancer Research At Ohio State COLUMBUS, Ohio – Six teams of scientists at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are each 12/22/2011
Study Reveals How Normal Cells Fuel Tumor Growth Research summary: · The study shows how normal cells in tumors can enhance the growth of the tumor’s cancer cells after losing an important tumor suppressor gene called Pten. · 12/21/2011
Hope Supports The New James Cancer Hospital And Solove Research Institute COLUMBUS, Ohio – A 31-foot steel beam carrying messages of hope for a cancer-free world from nearly 1,000 James cancer survivors will be installed at 10:30 a.m. Thursday (12/22) at the new Arthur G 12/21/2011
Scientists Discover Second-Oldest Gene Mutation COLUMBUS, Ohio – A new study has identified a gene mutation that researchers estimate dates back to 11,600 B.C., making it the second oldest human disease mutation yet discovered. Researchers wi 12/15/2011
Gene Mutation Signals A High Risk Of Recurrence In Some Older Acute-Leukemia Patients COLUMBUS, Ohio – Older people with acute myeloid leukemia and normal looking chromosomes in their cancer cells have a higher risk of recurrence if they have mutations in a gene called ASXL1, accordi 12/12/2011
Novel Export-Inhibitor Shows Promise For Treating CLL COLUMBUS, Ohio – An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) 12/12/2011
Interim Study Shows Novel Experimental Agent is Highly Active in CLL Patients COLUMBUS, Ohio – An interim analysis of a phase Ib/II clinical trial indicates that a novel experimental agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients w 12/9/2011
Ohio State Researchers Discover Hereditary Predisposition to Melanoma of the Eye COLUMBUS, Ohio – Ohio State University researchers have discovered a hereditary cancer syndrome that predisposes certain people to a melanoma of the eye, along with lung cancer, brain cancer and po 12/8/2011
Third Time In Three Years, The James Earns Top Hospital Status COLUMBUS, Ohio – For the third consecutive year and fourth time in five years, the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research I 12/6/2011
A New Study Suggests That A Neurotransmitter Might Improve The Treatment Of Cancer COLUMBUS, Ohio – Doses of a neurotransmitter might offer a way to boost the effectiveness of anticancer drugs and radiation therapy, according to a new study led by researchers at the Ohio State Univ Watch 12/5/2011
Ohio State Studying How Chemotherapy Affects Breast Cancer Patients’ Hearts COLUMBUS, Ohio – Ohio State University cancer and heart researchers are teaming up to find a better way to assess early cardiac injury from a class of chemotherapy drugs commonly used to treat breas Watch 12/5/2011
Lower Antioxidant Level Might Explain Higher Skin-Cancer Rate In Males COLUMBUS, Ohio – Men are three times more likely than women to develop a common form of skin cancer but medical science doesn’t know why. A new study may provide part of the answer. Researchers Watch 12/1/2011
Shapiro to Lead Breast Cancer Research Program at Ohio State COLUMBUS, Ohio – Dr. Charles Shapiro has been named to lead the breast cancer research program at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard 11/30/2011
Ohio State Cancer Expert Joins HemOnc Today Editorial Board COLUMBUS, Ohio – Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove 11/18/2011
NCI Funds Ohio State Breast Cancer Intervention Training COLUMBUS, Ohio – Barbara Andersen, a professor of psychology and researcher at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research I 11/18/2011
NCI Awards OSU Comprehensive Cancer Center $23 Million COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center (OSUCCC) has received a 5-year, $23 million core grant renewal from the National Cancer Institute (NCI) to support its broad 11/11/2011
Pelotonia 11 Raises A Record $13.1 Million COLUMBUS, Ohio -- Pelotonia has announced record fundraising of $13,108,639 for its 2011 ride. This year’s total reflects a 68% fundraising increase over the 2010 amount of $7,846,705. From August 11/11/2011
Stefanie's Champions Seeks Nominations for Caregivers COLUMBUS, Ohio – The 13th annual Stefanie’s Champions Awards is seeking nominations for caregivers who are helping improve the lives of cancer patients. Five Champions will be honored during an annua 11/9/2011
Ohio State Cancer Expert Receives NCI Award For Team Leadership COLUMBUS, Ohio – Dr. Tanios Bekaii-Saab, medical director of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solo 11/2/2011
Cancer Survivorship Research Reveals Disparities COLUMBUS, Ohio – Despite a general increase in research addressing cancer survivorship, researchers have found that a disproportionate number of studies focus on specific tumor sites, prevention, 10/31/2011
Ohio State Cancer Researcher Wins 11th Consecutive Research Grant COLUMBUS, Ohio – Ohio State University cancer researcher, Electra Paskett, has been awarded a grant from the Breast Cancer Research Foundation (BCRF) at the organization’s awards luncheon this week in 10/27/2011
New Oncolytic Virus Shows Improved Effectiveness In Preclinical Testing COLUMBUS, Ohio – A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal 10/27/2011
Internationally Renowned Oncologist Named Physician-In-Chief At Ohio State COLUMBUS, Ohio – Internationally renowned gastrointestinal oncologist Dr. Richard M. Goldberg has been named physician-in-chief at The Ohio State University Comprehensive Cancer Center – Arthur G. Ja Watch 10/27/2011
Ohio State Studies Whether Stress Affects HPV Vaccine Response COLUMBUS, Ohio – Ohio State University cancer researchers are studying whether stress impacts how the body’s immune system responds to the human papillomavirus (HPV) vaccine. The team of investigat 10/25/2011
Ohio State Dedicates Comprehensive Breast Center in Honor of Stefanie Spielman COLUMBUS, Ohio — The Ohio State University President E. Gordon Gee today announced the naming of The Stefanie Spielman Comprehensive Breast Center, in honor of the Ohio State alumna, philanthropist a 10/24/2011
Media Advisory: Ohio Mammography Day to Raise Awareness for Early Detection COLUMBUS, Ohio – Leaders of the Ohio Legislative Cancer Caucus, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUC 10/19/2011
Schottenstein Center To ‘Go Pink’ Today In Honor Of Breast Cancer Awareness Month COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James), The Kroger Company Columbus Division 10/19/2011
Nagy Elected President of National Genetic Counselors COLUMBUS, Ohio – Rebecca Nagy, a certified genetic counselor and researcher at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Res 10/13/2011
Ohio State Cancer Genetics Experts Available For Commentary MEDIA ADVISORY Leading cancer genetics experts from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute availab 10/11/2011
Breast Prosthesis Card Makes Travel Easier COLUMBUS, Ohio – Breast cancer survivors who have prostheses can now travel through airport security with more discretion by using a new identification card developed at the Ohio State University Com 10/7/2011
The James, Kroger and City Hall Team Up To Turn Central Ohio Pink COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James), The Kroger Company Columbus Division 9/29/2011
Media Advisory The James Offering Free Prostate Cancer Screenings COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) is offering free prostate cancer scre 9/27/2011
Novel Technique Reveals Both Gene Number And Protein Expression Simultaneously COLUMBUS, Ohio – Researchers have discovered a method for simultaneously visualizing gene number and protein expression in individual cells. The fluorescence microscopy technique could permit a detail 9/22/2011
Starving Cancer Cells Of Cholesterol Might Offer A New Way To Treat Brain Tumors COLUMBUS, Ohio – A new study suggests that blocking cancer cells’ access to cholesterol may offer a new strategy for treating glioblastoma, the most common and deadly form of brain cancer, and perhap 9/16/2011
James, Kenneth's Salons Team to Offer Screening, Gift COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and Kenneth’s Hair Salons & Day S 9/15/2011
Internationally Renowned Cancer Prevention Expert Takes Leadership Position At Ohio State COLUMBUS, Ohio – Dr. Peter G. Shields, an internationally renowned physician-scientist and expert in cancer prevention, is the new deputy director of The Ohio State University Comprehensive Cancer Ce Watch 9/7/2011
Medicated Patch Shows Promise in Oral Cancer Prevention COLUMBUS, Ohio – Researchers at The Ohio State University Comprehensive Cancer Center have developed a medicated oral patch that allows a chemoprevention drug to release directly into precancerous le Watch 9/1/2011
Annual Block Golf Tournament To Help Fund Expansion Project COLUMBUS, Ohio – The 28th Herbert J. Block Memorial Tournament benefiting The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institu 8/30/2011
Immunogene Therapy Combined With Standard Treatment Is Safe For Patients With Brain Tumors COLUMBUS, Ohio – A clinical trial has shown that a form of gene therapy is safe for treating a deadly form of brain cancer, even when combined with radiation therapy. The phase 1b trial was con Watch 8/15/2011
Pelotonia Fellowships Funding Ohio State Cancer Research COLUMBUS, Ohio – Each year, Pelotonia – a cycling event that raises money for cancer research at The Ohio State University – funds fellowship grants for undergraduate, graduate, medical school and pos 8/11/2011
Ohio State Names Cohn Director of Gynecologic Oncology COLUMBUS, Ohio – Dr. David E. Cohn (43209), a physician-scientist at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (O 8/9/2011